Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Secondary Spontaneous Pneumothorax
NCT03830645Phase 1Unknown
- Sponsor
- Zagazig University
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous platelet-rich plasma in secondary spontaneous pneumothorax (SSP), sponsored by Zagazig University. Primary endpoints: Air leak assessment by Cerfolio classification at 10 days, Physician assessment of complete lung inflation at 10 days and 1 more. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
secondary spontaneous pneumothorax (SSP)
Beyond the preview
Go deeper on NCT03830645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830645.